Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

PHASE3CompletedINTERVENTIONAL
Enrollment

626

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2014

Conditions
Iron Deficiency AnaemiaChronic Kidney Disease
Interventions
DRUG

FCM (Ferric carboxymaltose) high ferritin target

DRUG

FCM (Ferric carboxymaltose) low ferritin target

DRUG

Oral Iron (Ferrous sulphate)

Trial Locations (19)

141

Karolinska University Hospital, Stockholm

2250

Gosford Hospital - Renal Research, Gosford

6020

Medizinische Universität Innsbruck Univ.-Klinik für Innere Medizin IV, Innsbruck

7000

Lillebalt Frederica Sygehus Department of Nephrology, Frederica

7006

St. Olav's Hospital, Trondheim

7331

RHMS Baudour - Department of Nephrology and Dialysis, Baudour

17109

Praxis Dr. Kraatz, Demmin

28401

Trial Management Associates, Wilmington

38043

CHU grenoble - Service de Nephrologie, Grenoble

39008

Hospital Universitario Marqués de Valdecilla - Servicio de Nefrología, Santander

47100

General Hospital of Arta - Nephrology Department, Arta

74101

Nemocnice s poliklinikou v Novem Jicine, p.o. p.o. Interni oddeleni - nefrologie a dialyza, Nový Jičín

00042

Ospedali Riuniti Anzio-Nettuno ASL ROMA H U.O. Nefrologia e Dialisi, Anzio

3816 CP

Meander Medisch Centrum - Locatie Amersfoort Lichtenberg, Amersfoort

04-749

Miedzyleski Szpital Spec. Oddzial I Wewnetrzny I Nefrologii, Warsaw

1649-035

Hospital Santa Maria - Nefrologia, Lisbon

010731

"Spitalul Clinic de NefrologieDr Carol Davila", Bucharest

01330

Cukurova University Medical Faculty Balcali Hospital - Department of Nephrology, Adana

SE5 9RS

King's College Hospital, London

Sponsors
All Listed Sponsors
collaborator

American Regent, Inc.

INDUSTRY

collaborator

ICON Clinical Research

INDUSTRY

lead

Vifor Pharma

INDUSTRY